179 related articles for article (PubMed ID: 23342084)
1. Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.
Pio R; Jia Z; Baron VT; Mercola D;
PLoS One; 2013; 8(1):e54096. PubMed ID: 23342084
[TBL] [Abstract][Full Text] [Related]
2. Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer.
Baron VT; Pio R; Jia Z; Mercola D
Br J Cancer; 2015 Feb; 112(4):755-64. PubMed ID: 25633035
[TBL] [Abstract][Full Text] [Related]
3. Overexpressing miR‑335 inhibits DU145 cell proliferation by targeting early growth response 3 in prostate cancer.
Zhang P; Yang X; Wang L; Zhang D; Luo Q; Wang B
Int J Oncol; 2019 Jun; 54(6):1981-1994. PubMed ID: 31081063
[TBL] [Abstract][Full Text] [Related]
4. Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer.
Shin SH; Kim I; Lee JE; Lee M; Park JW
Oncogene; 2020 Sep; 39(36):5839-5854. PubMed ID: 32796959
[TBL] [Abstract][Full Text] [Related]
5. Decreased EGR3 expression is related to poor prognosis in patients with gastric cancer.
Liao F; Ji MY; Shen L; Qiu S; Guo XF; Dong WG
J Mol Histol; 2013 Aug; 44(4):463-8. PubMed ID: 23460371
[TBL] [Abstract][Full Text] [Related]
6. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
[TBL] [Abstract][Full Text] [Related]
7. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin.
Kumbrink J; Kirsch KH; Johnson JP
J Cell Biochem; 2010 Sep; 111(1):207-17. PubMed ID: 20506119
[TBL] [Abstract][Full Text] [Related]
8. Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action.
Chandra R; Francis TC; Konkalmatt P; Amgalan A; Gancarz AM; Dietz DM; Lobo MK
J Neurosci; 2015 May; 35(20):7927-37. PubMed ID: 25995477
[TBL] [Abstract][Full Text] [Related]
9. Identification of activity-induced Egr3-dependent genes reveals genes associated with DNA damage response and schizophrenia.
Marballi KK; Alganem K; Brunwasser SJ; Barkatullah A; Meyers KT; Campbell JM; Ozols AB; Mccullumsmith RE; Gallitano AL
Transl Psychiatry; 2022 Aug; 12(1):320. PubMed ID: 35941129
[TBL] [Abstract][Full Text] [Related]
10. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors.
Patwardhan S; Gashler A; Siegel MG; Chang LC; Joseph LJ; Shows TB; Le Beau MM; Sukhatme VP
Oncogene; 1991 Jun; 6(6):917-28. PubMed ID: 1906159
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas.
Knudsen AM; Eilertsen I; Kielland S; Pedersen MW; Sørensen MD; Dahlrot RH; Boldt HB; Munthe S; Poulsen FR; Kristensen BW
Sci Rep; 2020 Jun; 10(1):9285. PubMed ID: 32518380
[TBL] [Abstract][Full Text] [Related]
12. KSRP suppresses cell invasion and metastasis through miR-23a-mediated EGR3 mRNA degradation in non-small cell lung cancer.
Chien MH; Lee WJ; Yang YC; Li YL; Chen BR; Cheng TY; Yang PW; Wang MY; Jan YH; Lin YK; Lee JM; Hsiao M; Chen JS; Hua KT
Biochim Biophys Acta Gene Regul Mech; 2017 Oct; 1860(10):1013-1024. PubMed ID: 28847731
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells.
Inoue A; Omoto Y; Yamaguchi Y; Kiyama R; Hayashi SI
J Mol Endocrinol; 2004 Jun; 32(3):649-61. PubMed ID: 15171706
[TBL] [Abstract][Full Text] [Related]
14. Early Growth Response 3 (Egr3) Contributes a Maintenance of C2C12 Myoblast Proliferation.
Kurosaka M; Ogura Y; Funabashi T; Akema T
J Cell Physiol; 2017 May; 232(5):1114-1122. PubMed ID: 27576048
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-874-3p alleviates LPS-induced apoptosis and inflammation in alveolar epithelial cell by targeting EGR3/NF-κB.
Yang H; Dong Y; Zhou Y; Li H
Acta Biochim Pol; 2021 May; 68(2):231-238. PubMed ID: 34038062
[TBL] [Abstract][Full Text] [Related]
16. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.
Suzuki T; Inoue A; Miki Y; Moriya T; Akahira J; Ishida T; Hirakawa H; Yamaguchi Y; Hayashi S; Sasano H
Endocr Relat Cancer; 2007 Jun; 14(2):279-92. PubMed ID: 17639044
[TBL] [Abstract][Full Text] [Related]
17. Egr3 dependent sympathetic target tissue innervation in the absence of neuron death.
Li L; Eldredge LC; Quach DH; Honasoge A; Gruner K; Tourtellotte WG
PLoS One; 2011; 6(9):e25696. PubMed ID: 21980528
[TBL] [Abstract][Full Text] [Related]
18. EGR3 Is a Late Epidermal Differentiation Regulator that Establishes the Skin-Specific Gene Network.
Kim KH; Son ED; Kim HJ; Lee SH; Bae IH; Lee TR
J Invest Dermatol; 2019 Mar; 139(3):615-625. PubMed ID: 30342896
[TBL] [Abstract][Full Text] [Related]
19. Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3.
Zhao X; Ozols AB; Meyers KT; Campbell J; McBride A; Marballi KK; Maple AM; Raskin C; Mishra A; Noss SM; Beck KL; Khoshaba R; Bhaskara A; Godbole MN; Lish JR; Kang P; Hu C; Palner M; Overgaard A; Knudsen GM; Gallitano AL
Mol Psychiatry; 2022 Mar; 27(3):1599-1610. PubMed ID: 35001075
[TBL] [Abstract][Full Text] [Related]
20. Mice lacking the immediate early gene Egr3 respond to the anti-aggressive effects of clozapine yet are relatively resistant to its sedating effects.
Gallitano-Mendel A; Wozniak DF; Pehek EA; Milbrandt J
Neuropsychopharmacology; 2008 May; 33(6):1266-75. PubMed ID: 17637609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
